NASDAQ: ONCTOncternal Therapeutics Inc Stock Ownership - Who owns Oncternal Therapeutics?
Insider buying vs selling
Have Oncternal Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert James Wills | Director | 2024-04-08 | 3,086 | $8.96 | $27.65kBuy |
| Robert James Wills | Director | 2024-03-28 | 6,914 | $8.48 | $58.60kBuy |
| David F. Hale | Director | 2024-02-23 | 266 | $9.04 | $2.40kBuy |
| Robert James Wills | Director | 2024-02-23 | 980 | $9.04 | $8.86kSell |
| David F. Hale | Director | 2024-02-23 | 714 | $9.04 | $6.45kBuy |
| James B. Breitmeyer | Chief Executive Officer | 2024-01-03 | 4,485 | $0.50 | $2.22kSell |
| Salim Yazji | Chief Medical Officer | 2024-01-03 | 19,742 | $0.50 | $9.79kSell |
| James B. Breitmeyer | Chief Executive Officer | 2024-01-03 | 50,955 | $0.50 | $25.27kSell |
| Rajesh Krishnan | Chief Technical Officer | 2024-01-03 | 11,838 | $0.50 | $5.87kSell |
| Chase C. Leavitt | General CounselSecretary | 2024-01-03 | 11,838 | $0.50 | $5.87kSell |
ONCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ONCT insiders and whales buy or sell their stock.
ONCT Shareholders
What type of owners hold Oncternal Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph R. Hyde Iii | 807.11% | 23,887,655 | $26.75M | Insider |
| Mitchell Shuster Steiner | 324.93% | 9,616,728 | $10.77M | Insider |
| Jack W. Schuler | 235.30% | 6,964,028 | $7.80M | Insider |
| Shanghai Pharmaceutical Usa Inc | 204.06% | 6,039,545 | $6.76M | Insider |
| Peak Foundation Pyramid | 148.34% | 4,390,243 | $4.92M | Insider |
| Shanghai Pharmaceuticals Hk Investment Ltd | 35.45% | 1,049,317 | $1.18M | Insider |
| Marc Steven Hanover | 35.08% | 1,038,366 | $1.16M | Insider |
| David F. Hale | 25.31% | 749,056 | $838.94k | Insider |
| James B. Breitmeyer | 22.91% | 678,014 | $759.38k | Insider |
| J. Kenneth Glass | 8.41% | 248,818 | $278.68k | Insider |
ONCT vs Biotech Stocks
Oncternal Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.